106 related articles for article (PubMed ID: 27199208)
21. Improvement of Perioperative Outcomes in Major Gynecological and Gynecologic-Oncological Surgery with Hemostatic Gelatin-Thrombin Matrix.
Watrowski R; Jäger C; Forster J
In Vivo; 2017; 31(2):251-258. PubMed ID: 28358708
[TBL] [Abstract][Full Text] [Related]
22. Real-World Clinical and Economic Outcomes Associated with Surgiflo
Danker W; Aggarwal J; Kelkar SS; Marston XL; Gao X; Johnston SS
Clinicoecon Outcomes Res; 2022; 14():129-138. PubMed ID: 35299991
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial.
Kim HJ; Fraser MR; Kahn B; Lyman S; Figgie MP
J Bone Joint Surg Am; 2012 Jul; 94(13):1160-5. PubMed ID: 22623075
[TBL] [Abstract][Full Text] [Related]
24. Safety of the haemostatic agent Surgiflo® in excisions of the submandibular gland: our experience in 17 cases.
Bannister M; Ah-See K
Br J Oral Maxillofac Surg; 2014 Nov; 52(9):e134-5. PubMed ID: 25060975
[TBL] [Abstract][Full Text] [Related]
25. Use of a Topical Thrombin-Based Hemostatic Agent in Shoulder Arthroplasty.
Dhanota H; Pinkas D; Josserand D; Wiater BP; Koueiter DM; Wiater JM
Am J Orthop (Belle Mead NJ); 2015 Aug; 44(8):E262-7. PubMed ID: 26251940
[TBL] [Abstract][Full Text] [Related]
26. The effect of performance feedback on wound infection rate in abdominal hysterectomy.
Rodríguez JF; Trobo AR; García MV; Martínez MJ; Millán CP; Vázquez MC; Rodríguez JF; Pérez-Mendaña JM
Am J Infect Control; 2006 May; 34(4):182-7. PubMed ID: 16679174
[TBL] [Abstract][Full Text] [Related]
27. Thirty-day readmission and reoperation after surgery for spinal tumors: a National Surgical Quality Improvement Program analysis.
Karhade AV; Vasudeva VS; Dasenbrock HH; Lu Y; Gormley WB; Groff MW; Chi JH; Smith TR
Neurosurg Focus; 2016 Aug; 41(2):E5. PubMed ID: 27476847
[TBL] [Abstract][Full Text] [Related]
28. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors for Unscheduled 30-day Readmission after Benign Hysterectomy.
Catanzarite T; Vieira B; Qin C; Milad MP
South Med J; 2015 Sep; 108(9):524-30. PubMed ID: 26332476
[TBL] [Abstract][Full Text] [Related]
30. Patient factors associated with 30-day morbidity, mortality, and length of stay after surgery for subdural hematoma: a study of the American College of Surgeons National Surgical Quality Improvement Program.
Lukasiewicz AM; Grant RA; Basques BA; Webb ML; Samuel AM; Grauer JN
J Neurosurg; 2016 Mar; 124(3):760-6. PubMed ID: 26315000
[TBL] [Abstract][Full Text] [Related]
31. Resident participation in laparoscopic hysterectomy: impact of trainee involvement on operative times and surgical outcomes.
Igwe E; Hernandez E; Rose S; Uppal S
Am J Obstet Gynecol; 2014 Nov; 211(5):484.e1-7. PubMed ID: 24949539
[TBL] [Abstract][Full Text] [Related]
32. Gelatin-thrombin hemostatic matrix in neurosurgical procedures: hemostatic effectiveness and economic value of clinical and surgical procedure-related benefits.
Esposito F; Cappabianca P; Angileri FF; Cavallo LM; Priola SM; Crimi S; Solari D; Germanò AF; Tomasello F
J Neurosurg Sci; 2020 Apr; 64(2):158-164. PubMed ID: 27456032
[TBL] [Abstract][Full Text] [Related]
33. A comparative evaluation of hemostatic agents in the management of soft tissue graft donor site bleeding.
Rossmann JA; Rees TD
J Periodontol; 1999 Nov; 70(11):1369-75. PubMed ID: 10588501
[TBL] [Abstract][Full Text] [Related]
34. Novel hemostatic agents based on gelatin-microbial transglutaminase mix.
Lv F; Cong X; Tang W; Han Y; Tang Y; Liu Y; Su L; Liu M; Jin M; Yi Z
Sci China Life Sci; 2017 Apr; 60(4):397-403. PubMed ID: 28321657
[TBL] [Abstract][Full Text] [Related]
35. Injectable gelatin used as hemostatic agent to stop pedicle bleeding in long deformity surgical procedures: does it embolize?
Kuhns CA; Cook CR; Dodam JR; Leach SB; Kuroki K; Jenkins TJ; Tallmage AM; Hoernschemeyer DG
Spine (Phila Pa 1976); 2015 Feb; 40(4):218-23. PubMed ID: 25494314
[TBL] [Abstract][Full Text] [Related]
36. Predictors of 30-day readmission following hysterectomy for benign and malignant indications at a tertiary care academic medical center.
Lee MS; Venkatesh KK; Growdon WB; Ecker JL; York-Best CM
Am J Obstet Gynecol; 2016 May; 214(5):607.e1-607.e12. PubMed ID: 26704895
[TBL] [Abstract][Full Text] [Related]
37. [Modern topical hemostatic agents - a breakthrough in vascular surgery].
Janczak D; Ruciński A; Rucińska Z; Janczak D; Dorobisz K; Chabowski M
Polim Med; 2013; 43(4):221-5. PubMed ID: 24596036
[TBL] [Abstract][Full Text] [Related]
38. Blue-violet light-emitting diode irradiation in combination with hemostatic gelatin sponge (Spongel) application ameliorates immediate socket bleeding in patients taking warfarin.
Okamoto T; Ishikawa I; Kumasaka A; Morita S; Katagiri S; Okano T; Ando T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):170-7. PubMed ID: 24332521
[TBL] [Abstract][Full Text] [Related]
39. Use of a Thrombin-gelatin Hemostatic Matrix (Surgiflo) in Spinal Surgery.
Gazzeri R; De Bonis C; Galarza M
Surg Technol Int; 2014 Nov; 25():280-5. PubMed ID: 25419955
[TBL] [Abstract][Full Text] [Related]
40. Association between gelatin-thrombin matrix use and abscesses in women undergoing pelvic surgery.
Anderson CK; Medlin E; Ferriss AF; Sheeder J; Davidson S; Gibbs R; Behbakht K; Guntupalli SR
Obstet Gynecol; 2014 Sep; 124(3):589-595. PubMed ID: 25162261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
